Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. | J Immunother Cancer | 2023 | 37080610 | PubTator, text mining | PubMed |
| Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. | Cell Oncol (Dordr) | 2023 | 37079186 | PubTator, text mining | PubMed |
| Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1. | Front Cardiovasc Med | 2023 | 37077734 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines. | Front Pharmacol | 2023 | 37063287 | PubTator, text mining | PubMed |
| Unravelling the role of obesity and lipids during tumor progression. | Front Pharmacol | 2023 | 37063269 | PubTator, text mining | PubMed |
| HMGB1, angel or devil, in ischemic stroke. | Brain Behav | 2023 | 37062906 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. | Cancers (Basel) | 2023 | 37046685 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma. | Sci Adv | 2023 | 37043580 | PubTator, text mining | PubMed |
| PUREE: accurate pan-cancer tumor purity estimation from gene expression data. | Commun Biol | 2023 | 37041233 | PubTator, text mining | PubMed |
| Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction. | Med Oncol | 2023 | 37039909 | PubTator, text mining | PubMed |
| Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review. | J Nanobiotechnology | 2023 | 37029392 | PubTator, text mining | PubMed |
| Cellular heterogeneity and stem cells of vascular endothelial cells in blood vessel formation and homeostasis: Insights from single-cell RNA sequencing. | Front Cell Dev Biol | 2023 | 37025170 | PubTator, text mining | PubMed |
| Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. | Biomol Biomed | 2023 | 37021836 | PubTator, text mining | PubMed |
| Analysis and verification of the circRNA regulatory network RNO_CIRCpedia_ 4214/RNO-miR-667-5p/Msr1 axis as a potential ceRNA promoting macrophage M2-like polarization in spinal cord injury. | BMC Genomics | 2023 | 37020267 | PubTator, text mining | PubMed |
| Live Imaging of Monocyte/Macrophage Differentiation with Cationized Gelatin Nanospheres Incorporating a Molecular Beacon. | ACS Biomater Sci Eng | 2023 | 37014020 | PubTator, text mining | PubMed |
| Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. | World J Clin Oncol | 2023 | 37009528 | PubTator, text mining | PubMed |
| Impacts of vitrification on the transcriptome of human ovarian tissue in patients with gynecological cancer. | Front Genet | 2023 | 37007967 | PubTator, text mining | PubMed |
| RAGE signaling regulates the progression of diabetic complications. | Front Pharmacol | 2023 | 37007029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=27